| Troglitazone | Approved Withdrawn | ARNT2 | 9915 |
upregulated | troglitazone results in increased expression of ARNT2 mRNA | 15q25.1 | |
| Troglitazone | Approved Withdrawn | ASNS | 440 |
upregulated | troglitazone results in increased expression of ASNS mRNA | 7q21.3 | |
| Troglitazone | Approved Withdrawn | ASPA | 443 |
upregulated | troglitazone results in increased expression of ASPA mRNA | 17p13.2 | |
| Troglitazone | Approved Withdrawn | ASPM | 259266 |
downregulated | troglitazone results in decreased expression of ASPM mRNA | 1q31.3 | |
| Troglitazone | Approved Withdrawn | ASS1 | 445 |
upregulated | troglitazone results in increased expression of ASS1 mRNA | 9q34.11 | |
| Troglitazone | Approved Withdrawn | ATF3 | 467 |
downregulated | troglitazone results in decreased expression of ATF3 mRNA | 1q32.3 | |
| Troglitazone | Approved Withdrawn | ATF3 | 467 |
upregulated | troglitazone results in increased expression of ATF3 mRNA | 1q32.3 | |
| Troglitazone | Approved Withdrawn | ATG4A | 115201 |
upregulated | troglitazone results in increased expression of ATG4A mRNA | Xq22.3 | |
| Troglitazone | Approved Withdrawn | ATOH8 | 84913 |
downregulated | troglitazone results in decreased expression of ATOH8 mRNA | 2p11.2 | |
| Troglitazone | Approved Withdrawn | ATP5B | 506 |
downregulated | troglitazone results in decreased expression of ATP5B mRNA | 12q13.3 | |
| Troglitazone | Approved Withdrawn | ATP5J | 522 |
downregulated | troglitazone results in decreased expression of ATP5J mRNA | 21q21.3 | |
| Troglitazone | Approved Withdrawn | ATPIF1 | 93974 |
downregulated | troglitazone results in decreased expression of ATPIF1 mRNA | 1p35.3 | |
| Troglitazone | Approved Withdrawn | AURKB | 9212 |
downregulated | troglitazone results in decreased expression of AURKB mRNA | 17p13.1 | |
| Troglitazone | Approved Withdrawn | B4GALNT1 | 2583 |
upregulated | troglitazone results in increased expression of B4GALNT1 mRNA | 12q13.3 | |
| Troglitazone | Approved Withdrawn | BAX | 581 |
upregulated | troglitazone results in increased expression of BAX mRNA | 19q13.33 | |
| Troglitazone | Approved Withdrawn | BCCIP | 56647 |
downregulated | troglitazone results in decreased expression of BCCIP mRNA | 10q26.2 | |
| Troglitazone | Approved Withdrawn | BCL2 | 596 |
downregulated | troglitazone results in decreased expression of BCL2 mRNA | 18q21.33 | |
| Troglitazone | Approved Withdrawn | BCL2L1 | 598 |
downregulated | troglitazone results in decreased expression of BCL2L1 mRNA | 20q11.21 | |
| Troglitazone | Approved Withdrawn | BCL2L2 | 599 |
downregulated | troglitazone results in decreased expression of BCL2L2 mRNA | 14q11.2 | |
| Troglitazone | Approved Withdrawn | BHLHE40 | 8553 |
downregulated | troglitazone results in decreased expression of BHLHE40 mRNA | 3p26.1 | |
| Troglitazone | Approved Withdrawn | BIRC5 | 332 |
downregulated | troglitazone results in decreased expression of BIRC5 mRNA | 17q25.3 | |
| Troglitazone | Approved Withdrawn | BLM | 641 |
downregulated | troglitazone results in decreased expression of BLM mRNA | 15q26.1 | |
| Troglitazone | Approved Withdrawn | BNIP3L | 665 |
upregulated | troglitazone results in increased expression of BNIP3L mRNA | 8p21.2 | |
| Troglitazone | Approved Withdrawn | BRCA1 | 672 |
downregulated | troglitazone results in decreased expression of BRCA1 mRNA | 17q21.31 | |
| Troglitazone | Approved Withdrawn | BST1 | 683 |
downregulated | troglitazone results in decreased expression of BST1 mRNA | 4p15.32 | |